“…Brazil reported 50 cases of deficiency complement, followed by 13 reports of Argentina (Leiva et al, 2007). Like others studies, predominantly antibody deficiency was the principal PID observed in Latin America, Australia (Baumgart et al, 1997;Kirkpatrick et al, 2007), China (Zhao et al, 2006;Wang et al, 2011), Egypt (Reda et al, 2009), French (CEREDIH, 2010, Hong Kong (Lam et al, 2005), Iran (Aghamohammadi et al, 2002;Farhoudi et al, 2005;Rezaei et al, 2006), Italy (Luzi et al, 1983), Kuwait (AlHerz, 2008), Netherland (Zegers et al, 1994), Norway (Stray-Pedersen et al, 2000), Poland (Bernatowska et al, 1998), Republic of Ireland (Abuzakouk et al, 2005), Spain (Matamoros et al, 1997;Milá et al, 2001), Swiss (Ryser et al, 1998), Taiwan (Lee et al, 2011), Thailand (Benjasupattananan et al, 2009), Tunisia (Bejaoui et al, 1997) and USA (Javier et al, 2000;Stiehm, 2007), Studies in other countries reveled major number of granulocyte dysfunction in India (Verma et al, 2008), and Combined T-and B-cell Immunodeficiency in Turk (Shabestari et al, 2007).…”